Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hyaluronic Acid Gel and Concentrated Growth Factor in Periodontal Therapy

NCT07932912 is registered in ClinicalTrials.gov with Amina Fouad Farag as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07932912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hyaluronic Acid Gel and Concentrated Growth Factor in Periodontal Therapy
Lead sponsor
Amina Fouad Farag
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2023
Completion date
November 30, 2024
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 3 arms.

  • Group I: MINST Active comparatorMinimally invasive non-surgical therapy (MINST)

    Subgingival debridement under local anesthesia with 5× loupes and Gracey Mini Five curettes, using a subpapillary approach, without irrigation.

  • Group II: MINST + HA gel Experimental0.8% High-Molecular-Weight Hyaluronic Acid Gel, Minimally invasive non-surgical therapy (MINST)

    MINST followed by subgingival injection of 0.8% HA gel until overflow, repeated after 4 weeks.

  • Group III: MINST + CGF ExperimentalConcentrated Growth Factor (CGF), autologous, Minimally invasive non-surgical therapy (MINST)

    MINST followed by subgingival injection of CGF prepared from about 9 mL of venous blood (Medifuge, Silfradent), repeated after 4 weeks.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in Clinical Attachment Level (CAL) Baseline, 1 month, 3 months and 6 months after treatment

    Distance in millimetres from the cemento-enamel junction to the base of the pocket, measured at the experimental site (the deepest interproximal pocket) with a UNC-15 probe by a calibrated examiner. CAL gain = baseline CAL minus CAL at each follow-up. The 6-month CAL gain is the main end-point; the 1- and 3-month values describe the course of attachment gain.

Lead sponsor's other trials

Amina Fouad Farag, most recent start first.

Similar trials

Same condition (Periodontitis) and phase, most recent start first.